- Home
- ARVN vs HSTM Comparison
ARVN vs HSTM Comparison
Compare ARVN & HSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | HSTM |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 661.3M |
| IPO Year | 2018 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ARVN | HSTM |
|---|---|---|
| Price | $13.49 | $21.44 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 1 |
| Target Price | $15.57 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 743.8K | 396.0K |
| Earning Date | 05-27-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 0.66% |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | $262,600,000.00 | ★ $304,064,000.00 |
| Revenue This Year | N/A | $5.76 |
| Revenue Next Year | $1.94 | $4.85 |
| P/E Ratio | ★ N/A | $34.75 |
| Revenue Growth | N/A | ★ 4.26 |
| 52 Week Low | $5.90 | $19.50 |
| 52 Week High | $18.93 | $34.13 |
Technical Indicators
Market Signals| Indicator | ARVN | HSTM |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 52.73 |
| Support Level | $11.10 | $21.29 |
| Resistance Level | $13.97 | $22.56 |
| Average True Range (ATR) | 0.83 | 0.67 |
| MACD | 0.10 | 0.22 |
| Stochastic Oscillator | 81.83 | 49.17 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.